Indication
N/A
1 clinical trial
1 product
Clinical trial
A Phase 1 Single-center Study to Evaluate the Distribution of NT 201 Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery MethodsStatus: Completed, Estimated PCD: 2023-02-24
Product
IncobotulinumtoxinA